Sleep apnea and hypertension: Pathophysiologic mechanisms

Seminars in Nephrology

Volumn 22, Issue 1, 2002, Pages 71-77

  Richert, Allen ^a   Ansarin, Kahlil ^a   Baran, Alp Sinan ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; AROUSAL; COMORBIDITY; ELECTROENCEPHALOGRAM; HUMAN; HYPERTENSION; HYPOXEMIA; LUNG PRESSURE; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; SNORING;

GROWTH HORMONE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; OBESITY; SLEEP APNEA SYNDROMES;

EID: 0036141707     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Snoring and sleep apnoea in men: Association with central obesity and hypertension
2. The relative contribution of body fat and fat pattern to blood pressure level
3. Cardiovascular risk factors in snorers: A cross-sectional study of 3,323 men aged 54 to 74 years: The Copenhagen Male Study
4. Population-based study of sleep-disordered breathing as a risk factor for hypertension
5. Snoring and hypertension: A 10 year follow-up
6. Increased mortality among sleepy snorers: A prospective population based study
7. Sleep apnoea in a hypertensive population
8. Undiagnosed sleep apnea in patients with essential hypertension
9. Sleep apnea syndrome and essential hypertension
10. Sleep apnea and hypertension. A population-based study
11. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure
12. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea
13. Blood pressure and sleep apnea: Results of long-term nasal continuous positive airway pressure therapy
14. Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea
15. The effects of weight reduction on blood pressure in 301 obese patients
16. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients
17. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: Effects in "Non-Dippers"
18. Reduction in sympathetic activity long after long term CPAP treatment in sleep apnea-cardiovascular implications
19. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment
20. Hemodynamic changes during sleep
21. Systemic hemodynamics during sleep in young or middle-aged and elderly patients with essential hypertension
22. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas
23. Sleep stage influences the hemodynamic response to obstructive apneas
24. Stroke volume and cardiac output decrease at termination of obstructive apneas
25. Cardiac function during sleep
26. Changes in left ventricular ejection fraction during REM sleep and exercise in chronic obstructive pulmonary disease and sleep apnoea syndrome
27. Estimation of right and left ventricular size by ultrasound. A study of the echoes from the interventricular septum
28. Mechanical effects of inspiration on heart functions: A review
29. Left ventricular hemodynamics during respiration
30. Myocardiol interaction between the ventricles
31. Effects of normal and loaded spontaneous inspiration on cardiovascular function
32. Leftward septal displacement during right ventricular loading in man
33. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome
34. Bradycardia during sleep apnea. Characteristics and mechanism
35. The effects of artificially induced hyperventilation on the primary cardiac reflex response to stimulation of the carotid bodies in the dog
36. Gas exchange and hemodynamics during sleep
37. Hemodynamic studies in sleep apnea
38. Hypoxia augments apnea-induced peripheral vasoconstriction in humans
39. Periodic movements of the legs during sleep associated with rises in systemic blood pressure
40. Arterial blood pressure responses to graded transient arousal from sleep in normal humans
41. Role of sympathetic nervous system and neuropeptides in obesity hypertension
42. The adrenergic system and hypertension
43. Plasma catecholamines and essential hypertension: An analytical review
44. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage
45. Regional norepinephrine turnover in human hypertension
46. Sympathetic nervous system in hypertension: A potential long-term regulator of arterial pressure
47. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings
48. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
49. Role of the sympathetic nervous system in human hypertension
50. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea
51. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?
52. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension
53. Adrenergic hyperactivity and cardiac abnormality in primary disorders of sleep
54. Cardiopulmonary consequences of obstructive sleep apnea
55. Energy expenditure in obstructive sleep apnea: Effect of treatment with continuous positive airway pressure
56. Influence of treatment on muscle sympathetic nerve activity in sleep apnea
57. Sleep-disordered breathing and hypertension: Past lessons, future directions
58. Tracheostomy and hemodynamic changes in sleep-inducing apnea
59. Central hemodynamics and 24-hour blood pressure in obstructive sleep apnea syndrome: Effect of corrective surgery
60. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome
61. Avoiding the supine position during sleep lowers 24 h blood pressure in obstructive sleep apnea (OSA) patients
62. Cardiovascular responses to stimulation of the carotid body chemoreceptors in dog
63. 2 above 60 mm Hg
64. Role of hypoxemia in sleep apnea-induced sympathoexitation
65. Effects of repetitive airway obstruction on O2 saturation and systemic and pulmonary arterial pressure in anesthetized dogs
66. Sympathetic activation by hypoxia and hypercapnia - Implications for sleep apnea
67. Insulin resistance and hypertension: Patients in double jeopardy for cardiovascular disease
68. Obesity and hypertension: From pathophysiology to treatment
69. The pathophysiology of hypertension: The importance of angiotensin II in cardiovascular remodeling
70. Physiology and pathophysiology of the adipose tissue renin-angiotensin system
71. Mechanisms of hypertension and kidney disease in obesity
72. Growth hormone and the metabolic syndrome